Statistics

Total Visits

Views
cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients64

Select a period of time:

Number of views in the range

Views
cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients20

Views

Views
September 20256
October 20252
November 20257
December 20252
January 20260
February 20261
March 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
Brazil4
United Kingdom3
Argentina3
Finland1
Peru1
 

Top cities views

Views
Dallas6
Ashburn1
Buenos Aires1
Catamarca1
Comas1
Ezeiza1
Helsinki1
Itabaianinha1
Jaraguá1
João Pessoa1